Cefuroxime pharmacokinetics and pharmacodynamics for intravenous dosage regimens with 750 mg or 1500 mg doses in healthy young volunteers.

Conclusions. S. pneumoniae is most likely treatable with a two-daily dose of 750 mg cefuroxime. Not treatable are K. pneumoniae and E. coli. For S. aureus 1500 mg q8h constitutes an optimal dosing schedule. PMID: 31958049 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31958049?dopt=Abstract

Source: Journal of Medical Microbiology - January 19, 2020 Category: Microbiology Authors: Thønnings S, Jensen KS, Nielsen NB, Skjønnemand M, Hansen DS, Lange KHW, Frimodt-Møller N Tags: J Med Microbiol Source Type: research